Search - tctmd.com

Displaying 121 - 140 of 747

Sort: Relevancy | Date

News Daily News

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

Todd Neale

March 27, 2020

News Daily News

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

L.A. McKeown

March 09, 2020

News Daily News

Veterans Study Shows Areas of Need for CLI Care

L.A. McKeown

February 17, 2020

News Daily News

Sweeter Steps: Cocoa May Boost Walking Ability in PAD

L.A. McKeown

February 14, 2020

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

L.A. McKeown

February 11, 2020

News Daily News

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

L.A. McKeown

January 15, 2020

News Daily News

Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI

L.A. McKeown

January 09, 2020

News Daily News

ACC/AHA Guideline Writers’ Disclosures vs Open Payments Don’t Add Up

Caitlin E. Cox

December 05, 2019

News Daily News

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Caitlin E. Cox

October 21, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Daily News

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

Caitlin E. Cox

September 20, 2019

News Daily News

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

L.A. McKeown

September 16, 2019

News Daily News

Early Signs Positive for Tendyne TMVR in Severe MAC

Caitlin E. Cox

September 11, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Daily News

Aborted TAVR Procedures Are Waning in the US

Shelley Wood

August 28, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

Advertisement

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

Veterans Study Shows Areas of Need for CLI Care

Sweeter Steps: Cocoa May Boost Walking Ability in PAD

Outcome Differences Between Men and Women With PAD: EUCLID Insights

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI

ACC/AHA Guideline Writers’ Disclosures vs Open Payments Don’t Add Up

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

FDA Gives Rivaroxaban Another VTE-Related Indication

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

Early Signs Positive for Tendyne TMVR in Severe MAC

TCTMD’s Top 10 Most Popular Stories for August 2019

Aborted TAVR Procedures Are Waning in the US

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content